Literature DB >> 24991011

Homeostatic cytokines induce CD4 downregulation in African green monkeys independently of antigen exposure to generate simian immunodeficiency virus-resistant CD8αα T cells.

Molly R Perkins1, Judith A Briant1, Nina Calantone1, Sonya Whitted1, Carol L Vinton1, Nichole R Klatt1, Ilnour Ourmanov1, Alexandra M Ortiz1, Vanessa M Hirsch1, Jason M Brenchley2.   

Abstract

UNLABELLED: African green monkeys (AGMs; genus Chlorocebus) are a natural host of simian immunodeficiency virus (SIVAGM). As they do not develop simian AIDS, there is great interest in understanding how this species has evolved to avoid immunodeficiency. Adult African green monkeys naturally have low numbers of CD4 T cells and a large population of major histocompatibility complex class II-restricted CD8α(dim) T cells that are generated through CD4 downregulation in CD4(+) T cells. Mechanisms that drive this process of CD4 downregulation are unknown. Here, we show that juvenile AGMs accelerate CD4-to-CD8αα conversion upon SIV infection and avoid progression to AIDS. The CD4 downregulation induced by SIV infection is not limited to SIV-specific T cells, and vaccination of an adult AGM who had a negligible number of CD4 T cells demonstrated that CD4 downregulation can occur without antigenic exposure. Finally, we show that the T cell homeostatic cytokines interleukin-2 (IL-2), IL-7, and IL-15 can induce CD4 downregulation in vitro. These data identify a mechanism that allows AGMs to generate a large, diverse population of T cells that perform CD4 T cell functions but are resistant to SIV infection. A better understanding of this mechanism may allow the development of treatments to induce protective CD4 downregulation in humans. IMPORTANCE: Many African primate species are naturally infected with SIV. African green monkeys, one natural host species, avoid simian AIDS by creating a population of T cells that lack CD4, the human immunodeficiency virus/SIV receptor; therefore, they are resistant to infection. However, these T cells maintain properties of CD4(+) T cells even after receptor downregulation and preserve immune function. Here, we show that juvenile AGMs, who have not undergone extensive CD4 downregulation, accelerate this process upon SIV infection. Furthermore, we show that in vivo, CD4 downregulation does not occur exclusively in antigen-experienced T cells. Finally, we show that the cytokines IL-2, IL-7, and IL-15, which induce homeostatic T cell proliferation, lead to CD4 downregulation in vitro; therefore, they can provide signals that lead to antigen-independent CD4 downregulation. These results suggest that if a similar process of CD4 downregulation could be induced in humans, it could provide a cure for AIDS.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24991011      PMCID: PMC4178902          DOI: 10.1128/JVI.01331-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virus.

Authors:  S Goldstein; I Ourmanov; C R Brown; B E Beer; W R Elkins; R Plishka; A Buckler-White; V M Hirsch
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites.

Authors:  Ivona Pandrea; Nicholas F Parrish; Kevin Raehtz; Thaidra Gaufin; Hannah J Barbian; Dongzhu Ma; Jan Kristoff; Rajeev Gautam; Fang Zhong; George S Haret-Richter; Anita Trichel; George M Shaw; Beatrice H Hahn; Cristian Apetrei
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  CD4 and CD8 expressions in African green monkey helper T lymphocytes: implication for resistance to SIV infection.

Authors:  Y Murayama; A Amano; R Mukai; H Shibata; S Matsunaga; H Takahashi; Y Yoshikawa; M Hayami; A Noguchi
Journal:  Int Immunol       Date:  1997-06       Impact factor: 4.823

4.  SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination.

Authors:  Nichole R Klatt; Carol L Vinton; Rebecca M Lynch; Lauren A Canary; Jason Ho; Patricia A Darrah; Jacob D Estes; Robert A Seder; Susan L Moir; Jason M Brenchley
Journal:  Blood       Date:  2011-09-29       Impact factor: 22.113

5.  An African green monkey lacking peripheral CD4 lymphocytes that retains helper T cell activity and coexists with SIVagm.

Authors:  Y Murayama; R Mukai; M Inoue-Murayama; Y Yoshikawa
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  Quantifying T lymphocyte turnover.

Authors:  Rob J De Boer; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-01-09       Impact factor: 2.691

7.  Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replication.

Authors:  V M Hirsch; G Dapolito; P R Johnson; W R Elkins; W T London; R J Montali; S Goldstein; C Brown
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host.

Authors:  B Beer; J Denner; C R Brown; S Norley; J zur Megede; C Coulibaly; R Plesker; S Holzammer; M Baier; V M Hirsch; R Kurth
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-07-01

9.  Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection.

Authors:  Vasudha Sundaravaradan; Ramsey Saleem; Luca Micci; Melanie A Gasper; Alexandra M Ortiz; James Else; Guido Silvestri; Mirko Paiardini; John D Aitchison; Donald L Sodora
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

10.  SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations.

Authors:  Dongzhu Ma; Anna Jasinska; Jan Kristoff; J Paul Grobler; Trudy Turner; Yoon Jung; Christopher Schmitt; Kevin Raehtz; Felix Feyertag; Natalie Martinez Sosa; Viskam Wijewardana; Donald S Burke; David L Robertson; Russell Tracy; Ivona Pandrea; Nelson Freimer; Cristian Apetrei
Journal:  PLoS Pathog       Date:  2013-01-17       Impact factor: 6.823

View more
  6 in total

1.  Interleukin-2 Therapy Induces CD4 Downregulation, Which Decreases Circulating CD4 T Cell Counts, in African Green Monkeys.

Authors:  Joseph C Mudd; Molly R Perkins; Sarah R DiNapoli; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

2.  Epigenetic Reprogramming Leads to Downregulation of CD4 and Functional Changes in African Green Monkey Memory CD4+ T Cells.

Authors:  Andrew R Rahmberg; Tovah E Markowitz; Joseph C Mudd; Vanessa Hirsch; Jason M Brenchley
Journal:  J Immunol       Date:  2022-06-24       Impact factor: 5.426

3.  Cytotoxic T Cell Functions Accumulate When CD4 Is Downregulated by CD4+ T Cells in African Green Monkeys.

Authors:  Carol L Vinton; Alexandra M Ortiz; Nina Calantone; Joseph C Mudd; Claire Deleage; David R Morcock; Sonya Whitted; Jacob D Estes; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Immunol       Date:  2017-04-24       Impact factor: 5.422

4.  Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.

Authors:  Abigail Lara; Yu Cong; Peter B Jahrling; Mark Mednikov; Elena Postnikova; Shuiqing Yu; Vincent Munster; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2019-06-05

5.  Multivariate profiling of African green monkey and rhesus macaque T lymphocytes.

Authors:  Wail M Hassan; Gregory F Burton; Gabriella A Pinter; Istvan G Lauko; Nader N Mahdi; Mackenzie E Johnson
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

6.  Epigenetic silencing of CD4 expression in nonpathogenic SIV infection in African green monkeys.

Authors:  Joseph C Mudd; Stephen Lai; Sanjana Shah; Andrew Rahmberg; Jacob K Flynn; Carly E Starke; Molly R Perkins; Amy Ransier; Sam Darko; Daniel C Douek; Vanessa M Hirsch; Mark Cameron; Jason M Brenchley
Journal:  JCI Insight       Date:  2020-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.